ISLET SCIENCES, INC. DIRECTOR AGREEMENTDirector Agreement • March 14th, 2014 • Islet Sciences, Inc • Blank checks • New York
THIS AGREEMENT (the "Agreement") is made as of the ___ day of March 2014 and is by and between Islet Sciences, Inc., a Nevada corporation (hereinafter referred to as the "Company"), and Michael Luther (hereinafter referred to as the "Director").
Brighthaven Ventures L.L.C./Islet Sciences, Inc. BINDING LETTER OF INTENT For the Acquisition of Brighthaven Ventures, L.L.C.Islet Sciences, Inc • March 14th, 2014 • Blank checks
This Letter of Intent (this “Letter of Intent”) sets forth the agreement of the parties hereto for Islet Sciences, Inc. (together with any newly organized parent company of Islet Sciences, Inc. utilized in a restructuring of Islet Sciences, Inc. or in connection with the transactions contemplated herein, “Islet”) to acquire 100% of the issued and outstanding interests (the “Interests”)_ in Brighthaven Ventures L.L.C., d/b/a BHV Pharma (“BHV”). As described below, the parties hereby agree to negotiate in good faith to execute definitive agreements in connection with the transactions contemplated by this Letter of Intent. However, it is expressly understood that this Letter of Intent shall itself be contractually binding regardless of whether or not a further agreement is executed, subject to the terms and conditions described herein.
